ClinicalTrials.gg
CompletedNCT06070792Updated Sep 19, 2024

Neurolinguistic Programming, Progressive Muscle Relaxation Exercises, and Breastfeeding

An interventional study of NEURO LINGUISTIC PROGRAM and PROGRESSIVE MUSCLE RELAXATION EXERCISES in NEUROLINGUISTIC PROGRAMMING, PROGRESSIVE MUSCLE RELAXATION EXERCISES and CAESAREAN SECTION, sponsored by Aysegul Kilicli. Completed at 1 site in Turkey. Open to female participants aged 19 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Aysegul Kilicli · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
99
Allocation
Randomized
Ages
19 Years to 35 Years
Sex
Female
01

Study summary

The effect of neuro linguistic program and progressive muscle relaxation exercises on breastfeeding success and breastfeeding self-efficacy after caesarean section.

Read the detailed description

In this research, it is aimed to detemine the effect of neuro linguistic program and progressive muscle relaxation exercises on breastfeeding success and breastfeeding self-efficacy after caesarean section.

Sample size:

  • There will be three groups in the study (two experimental groups and one control group).
  • The sample size of the study is 99 people. The sample size will be divided into three and 33 people will be randomly assigned to each group.
  • Experiment 1 group: neuro linguistic programme (NLP) group.
  • Experiment 2 group: progressive muscle relaxation exercises (PMRE) group.
  • Control group: non-intervention group

Data Collection Tools;

  • Introductory Information Form,
  • Breastfeeding Self-Efficacy Scale,
  • Breastfeeding Charting System (LATCH)

Application time:

  • NLP and PMRE interventions will be started at the sixth postoperative hour after caesarean section.
  • Mothers who give birth by caesarean section are followed up in hospital for 48 hours and mothers are then discharged when their health condition improves. Therefore, data will be collected within 48 hours after caesarean section.
  • NLP and PMRE groups will be started at the sixth postoperative hour, 3 times in 24 hours on the first day, 3 times in 24 hours on the second day, six times in total.
  • Only NLP and PMRE will not be applied to the control group.
  • Care and follow-up will be performed in parallel with the individuals in the experimental group.

Measurement time:

  • Mothers will fill in the Introductory Information Form, Breastfeeding Self-Efficacy Scale, Breastfeeding Diagnosis and Assessment Measurement Tool (LATCH) before the application at the sixth postoperative hour.
  • Then, in the first 24 hours, the necessary application will be performed once every eight hours according to the groups (for example, NLP application for experiment 1).
  • At the end of 24th hour, Breastfeeding Self-Efficacy Scale and Breastfeeding Diagnosis and Assessment Measurement Tool (LATCH) will be completed.
  • Then, in the second 24 hours, the interventions will be repeated once every eight hours.
  • The total number of application sessions is six.
  • NLP application will last 20 minutes each session and PMRE application will last 20 minutes each session.
02

Conditions studied

  • NEUROLINGUISTIC PROGRAMMING
  • PROGRESSIVE MUSCLE RELAXATION EXERCISES
  • CAESAREAN SECTION

Keywords

  • NEURO LINGUISTIC PROGRAM
  • PROGRESSIVE MUSCLE RELAXATION EXERCISES
  • CAESAREAN SECTION
  • BREASTFEEDING SUCCESS
  • BREASTFEEDING SELF-EFFICACY
03

In context

Lead sponsor

Aysegul Kilicli is the lead sponsor of 6 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • women who gave birth by caesarean section,
  • primiparous,
  • who are 19 years of age or older and 35 years of age or younger,
  • who were born at 37 or more weeks of gestation,
  • who had a singleton birth,
  • whose caesarean section operation was performed with spinal anaesthesia,
  • who do not have chronic diseases and any breast-related health problems .

Exclusion criteria

Exclusion Criteria:

  • mothers who did not meet the inclusion criteria,
  • who wanted to leave the study voluntarily at any stage after being included in the study,
  • who developed any health problems in themselves or their infants were excluded.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
99 participants (actual)

Study arms

  • Experimental
    NEURO LINGUISTIC PROGRAM

    first experimental group. It will be administered to primiparous mothers after caesarean section in the first 48 hours after the sixth postoperative hour, once every eight hours, for a total of six times. Each session will last 20 minutes. In the NLP application; firstly, the most frequently used visual, auditory and/or tactile representation system of the woman will be determined. Then, the internal and external reactions caused by the symptoms after caesarean section, her feelings and thoughts about her baby and breastfeeding will be combined with the anchoring technique. Then, with the swish technique, the existing negative emotions will be reduced and tried to be deleted from the most frequently used representation system. The woman's negative thoughts about breastfeeding will be changed in a positive direction with the belief change model.

    Other: NEURO LINGUISTIC PROGRAM

  • Experimental
    PROGRESSIVE MUSCLE RELAXATION EXERCISES

    second experimental group. It will be administered to primiparous mothers after caesarean section in the first 48 hours after the sixth postoperative hour, once every eight hours, for a total of six times. Each session will last 20 minutes. PMRE; All muscles of the body will be tried to be relaxed respectively with the commands given gradually.

    Other: PROGRESSIVE MUSCLE RELAXATION EXERCISES

  • No intervention
    control

    The control group will not receive NLP or PMRE.

Interventions

  • OtherNEURO LINGUISTIC PROGRAM

    NEURO LINGUISTIC PROGRAM

  • OtherPROGRESSIVE MUSCLE RELAXATION EXERCISES

    PROGRESSIVE MUSCLE RELAXATION EXERCISES

06

What researchers measure

Primary outcomes

  1. BREASTFEEDING SUCCESS

    Breastfeeding Charting System (LATCH); The measurement tool has no cut-off point, and as the LATCH score increases, it is understood that the process is high. The maximum score that can be obtained is 10. The sum of lower scores indicates that the mother is dependent on help.

    Time frame: immediately before the first application

  2. BREASTFEEDING SUCCESS

    Breastfeeding Charting System (LATCH)

    Time frame: immediately after the third application (at the 24th hour after the first application)

  3. BREASTFEEDING SUCCESS

    Breastfeeding Charting System (LATCH)

    Time frame: immediately after the sixth application (at the 48th hour after the first application)

  4. BREASTFEEDING SELF-EFFICACY

    Breastfeeding Self-Efficacy Scale; A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All are positive elements. The higher the score from the scale, the higher breastfeeding self-efficacy will be achieved.

    Time frame: immediately before the first application

  5. BREASTFEEDING SELF-EFFICACY

    Breastfeeding Self-Efficacy Scale

    Time frame: immediately after the third application (at the 24th hour after the first application)

  6. BREASTFEEDING SELF-EFFICACY

    Breastfeeding Self-Efficacy Scale

    Time frame: immediately after the sixth application (at the 48th hour after the first application)

07

Study locations

1 site
  • Şanlıurfa training and research hospital
    Şanlıurfa, Eyalet/Yerleşke 63000, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2023 to primary completion in Dec 2023, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 19, 2023
First posted
Oct 6, 2023
StartActual
Oct 1, 2023
Primary completionActual
Dec 18, 2023
CompletionActual
Dec 18, 2023
Last update
Sep 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06070792
Lead sponsor
Aysegul Kilicli
Responsible party
Aysegul Kilicli (Gaziantep University Health Sciences Enstıtute, Department of Nursing, Department of Obstetrics and Gynaecology Nursing, PhD., University of Gaziantep) — Sponsor-investigator
First posted
Oct 6, 2023
Start date
Oct 1, 2023
Primary completion
Dec 18, 2023
Completion
Dec 18, 2023
Last update
Sep 19, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion